
Utility Therapeutics, which was founded by the same team as Danish biotech company Union Therapeutics, has almost achieved an important goal.
The company reports that it is almost ready to send an application to the US Food and Drug Administration (FDA) for the use of one of its two antibiotic products, which are the backbone of the company's business. Utility Therapeutics expects to send the application in Q4 2021.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app